机构:[1]Department of Obstetrics and Gynecology, Hebei Medical University, Fourth Hospital河北医科大学第四医院妇科临床科室[2]Department of Molecular Biology, Hebei Cancer Institute, Shijiazhuang, China.临床科室医技科室河北省肿瘤研究所分子生物学室河北医科大学第四医院
Objective: This study was to investigate the association of p73 G4C14-to-A4T14 and Murine Double Minute2 (MDM2) 309T/G, De11518+/- single nucleotide polymorphisms with the risk of epithelial ovarian cancer (EOC) in Chinese. Materials and Methods: This hospital-based case-control study included 257 ovarian cancer patients and 257 healthy women who were matched for age. p73 and MDM2 genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism. Results: There were no significant differences in allele frequencies and genotype distributions of the p73 G4C14-to-A4T14 polymorphism between cases and control women (P = 0.55 and 0.20, respectively). The frequencies of the G allele of the MDM2 309T/G polymorphism were significantly lower in ovarian cancer cases (46.7%) than those in healthy controls (54.7%), there was a statistical difference between the 2 groups (P = 0.01). Compared with the TIT genotype, the G allelotype (T/G+G/G genotype) significantly decreased the risk of developing EOC (odds ratio, 0.65; 95% confidence interval, 0.44-0.97). Although MDM2 Dell518+/- genotypes and allele frequencies did not differ between the case and the control groups (P = 0.68 and P = 0.45), Del1518 +/+ genotype tended to increase the risk of mucinous ovarian cancer or earlier ovarian cancer by stratification analysis according to histological subtypes or clinical stage. Besides, there was a significant interaction between p 73 G4C14-to-A4T14 and MDM2 309T/G polymorphisms by the likelihood ratio test (P = 0.03; odds ratio, 0.89; 95% confidence interval, 0.80-0.99). Conclusion: The MDM2 SNP309G allele significantly decreased the risk of EOC and might be a potentially protective factor for EOC development in Chinese women.
基金:
Hebei Universities; The Scientific Technique Program of the Research and Development in Hebei Province
第一作者机构:[1]Department of Obstetrics and Gynecology, Hebei Medical University, Fourth Hospital
通讯作者:
通讯机构:[2]Department of Molecular Biology, Hebei Cancer Institute, Shijiazhuang, China.[*1]Department of Molecular Biology, Hebei Cancer Institute, Hebei Medical University, Fourth Hospital, Jiankanglu 12, Shijiazhuang 050011, China.
推荐引用方式(GB/T 7714):
Kang Shan,Wang Dong-Jie,Li Wan-Sheng,et al.Association of p73 and MDM2 Polymorphisms With the Risk of Epithelial Ovarian Cancer in Chinese Women[J].INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER.2009,19(4):572-577.doi:10.1111/IGC.0b013e3181a130ab.
APA:
Kang, Shan,Wang, Dong-Jie,Li, Wan-Sheng,Wang, Na,Zhou, Rong-Miao...&Li, Yan.(2009).Association of p73 and MDM2 Polymorphisms With the Risk of Epithelial Ovarian Cancer in Chinese Women.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER,19,(4)
MLA:
Kang, Shan,et al."Association of p73 and MDM2 Polymorphisms With the Risk of Epithelial Ovarian Cancer in Chinese Women".INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 19..4(2009):572-577